✦ LIBER ✦

748 Trimetrexate (TMTX) modulation of 5-fluorouracil/leucovorin (5-FU/LV) for advanced colorectal cancer

✍ Scribed by C. Blanke; B. Kasimis; P. Schein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

863 - Trimetrexate (TMTX) modulation of

✍ F. Cvitkovic; R. Mahjoubi; W. Oster; N. Habboubi; M. Mita; J.M. Vannetzel 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Phase III trial of 5-fluorouracil (5FU)

✍ C.J.A. Punt; H.J. Keizer; J. Douma; J. Schüller; T. Skovsgaard; C.H.H. ten Napel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Integrated analysis of overall survival

✍ Punt, C.J.A.; Blanke, C.D.; Skovsgaard, T.; Schulz, J.J.; Oster, W.; Keizer, H.J 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 361 KB

PCN6 ECONOMICAL EVALUATION OF RALTITREXE

✍ P Vorobyov; M Sura; M Avxentieva; V Papsheva 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Nutritional Status of Colorectal Cancer

✍ K Ried; A Voss; F Cope; W. Dugan; L Laughman; R Chlebowski 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 164 KB

755 - A phase II trial of trimetrexate (

✍ E.D. Kreuser; H. Szelenyi; P. Hohenberger; H. Lochs; N. Habboubi; W. Oster; E. T 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 260 KB